GEN Exclusives

More »

GEN News Highlights

More »
Apr 28, 2008

Brain and BioSilta to Develop Enzyme Expression and Discovery Technologies

  • Brain and BioSilta agreed to work together to advance tools for protein expression and enzyme discovery. The partnership will leverage BioSilta’s EnBase cell culture platform.

    Under the terms of the agreement, Brain gains access to EnBase, while BioSilta obtains access to application-relevant process developments.

    The goal is to optimize microwell plate-based high cell density protein expression and high-throughput enzyme discovery technologies. EnBase will be used to accelerate enzyme discovery and improve expression of enzymes.  The product is characterized by enzyme-based substrate delivery from a polymer layer to the cultivation medium for high-throughput screening with expression libraries and commercially relevant microbial host strains.

    “We enable customers to improve the yield and the quality of simple bacterial cultures,” according to Russell Golson, CEO of BioSilta. “You can obtain up to 50 times more bacteria and consequently higher amount of recombinant proteins in the same volume with our innovative EnBase products.”


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »